LifeAhead

Personalized forecasts of reproductive lifespan. Discover your fertility and menopause timelines, years out.

[LifeAhead @Lifeaheadinc]

https://t.co/W3fIcqlvf3

[LifeAhead @Lifeaheadinc]

Doctors are calling for earlier, more accessible fertility screening.

The conversation should happen at 28, not at 38 in a fertility clinic. It belongs in the annual visit everyone has.

The tools to make that routine don't exist yet. That's what we're building.

[LifeAhead @Lifeaheadinc]

Essential read from @rivatez. AMH is a stimulation-response test, not a fertility clock. There is still a gap in the knowledge women were promised, and we are trying to close it, by building what AMH has been sold as: a long-range forecast of the end of the ovarian reserve.

[Riva @rivatez]

https://t.co/hGg079IMws

[LifeAhead @Lifeaheadinc]

Efforts in ovarian aging research are finally getting the limelight they deserve.

Huge shoutout to our grassroots supporters at @athena_DAO_ for their mention in @TIME .

We’re proud to be part of the community turning these biological mysteries into better understanding.

[LifeAhead @Lifeaheadinc]

@WIRED @EricTopol https://t.co/w1Jx4Sx2wD

[LifeAhead @Lifeaheadinc]

Precision medical forecasting is coming.

In @WIRED, @EricTopol predicts that in 2026 deep data will enable new frontiers in health.

We’re developing a forecasting tool that transforms reproductive timelines into actionable medicine. The era of proactive women's health is here.

[LifeAhead @Lifeaheadinc]

@EricTopol Link to the Wired piece:
https://t.co/sB1fmE14TO

[LifeAhead @Lifeaheadinc]

@EricTopol in Wired highlights a shift coming in 2026: the move toward primary prevention.

We're building exactly this this year. Our forecasting tool delivers the 'temporal arc' for perimenopause that Topol identified as a critical unmet need. Stay tuned for big news in 2026.

[LifeAhead @Lifeaheadinc]

We’re excited to be collaborating with @HITLABnyc to continue to refine our reproductive lifespan forecasting tools for use in the clinic. Together, we're preparing full, robust usability documentation for the FDA for approval as a medical device

https://t.co/QeH459FHos

[LifeAhead @Lifeaheadinc]

The FDA has finally removed the black box warning from hormone replacement therapy. After years of misplaced caution, policy is catching up to the science.

This marks a turning point for menopause care. A new era of more proactive, personalized midlife care is beginning.

[LifeAhead @Lifeaheadinc]

Early menopause carries huge costs for health, but just how much has never been quantified. We sponsored an AIxHackathon challenge to find an answer.

The winning project, https://t.co/IAmwrezf0Z, beautifully shows how extending ovarian healthspan could transform women’s health.

[LifeAhead @Lifeaheadinc]

What if you could know when menopause will begin years in advance?

On the Boombostic Health pod, we shared how LifeAhead is using cutting-edge science to more precisely forecast the menopausal transition, empowering women to plan with confidence.

https://t.co/5y1FQW7Hqm

[LifeAhead @Lifeaheadinc]

We're launching soon. Stay informed below to get updated when we do!

[AthenaBIO 🧬🪩 @athenabiorg]

@LifeAheadinc’s first-ever personalized reproductive forecasting tool is launching soon!

If you’re interested in their plans for release and couldn’t make it to their presentation at AthenaDAO’s Demo Day, use the QR code below to get on the waitlist👇

[LifeAhead @Lifeaheadinc]

@johnsonlab's ovarian-reserve model mentioned in @USATODAY is the engine behind @Lifeaheadinc. We’re translating this science into a tool that will not only empower women but support future ovarian aging research. Big thanks to @AthenaDAO for backing the journey, and to @USATODAY

[AthenaBIO 🧬🪩 @athenabiorg]

🗞️ IN THE NEWS! 🗞️

AthenaDAO was recently featured on an amazing article in @USATODAY of ovarian heath beyond fertility and menopause!

Our work on funding women’s health research was mentioned  as well as Dr. Joshua Johnson’s (@johnsonlab) - one of our funded researchers - Mathematical model. The model is the basis for the proprietary algorithm of the first spinout we supported out of academia: LifeAhead (@Lifeaheadinc).

The article features the most important names in ovarian aging including Dr. Jennifer Garrison (@jenngarrison) amongst others. 

We are honored.

The article is a MUST READ to learn on how women’s health is impacted by ovarian aging.

Thank you @KZaiets and art direction by Veronica Bravo.

🔗 Below

[AthenaBIO 🧬🪩 @athenabiorg]

📣TL;DR on @athena_DAO_ Demo Day projects on our latest newsletter

✅ Decentralized fertility clinical trial w/ @OvulOfficial
✅ $1B+ GeroAI x Chugai deal
✅ Ovarian cryopreservation with ProFaM
✅ Our first Repro longevity AI agent with @CoopHive
✅ @Lifeaheadinc
…and more

[LifeAhead @Lifeaheadinc]

"Unlike other organs where function can be measured with routine tests, there is no simple diagnostic tool to track ovarian aging.”

That knowledge gap drives what we’re building at LifeAhead - the first personalized forecast for reproductive decline.

https://t.co/pCek04Bw8N

[LifeAhead @Lifeaheadinc]

Excited to share that we will be joining @athena_DAO_ 's Demo Day on Wednesday June 25th, 12pm ET!

We will be talking about our first of it's kind forecast for reproductive lifespan - find out your timeline to perimenopause and menopause decade prior
@JSH_JHNSN

[AthenaBIO 🧬🪩 @athenabiorg]

@simonfishel_ivf @hacking_aging @CorderoMarioD @pablodeolavide What if there was a diagnostic to calculate when your fertility ends? Meet the academic spin out AthenaDAO is supporting to do this. 

Hear from Dr. Joshua Johnson @JSH_JHNSN of @johnsonlab @cuanschutz and Dr. Nicholas Gentry @nichgentry, founder of @Lifeaheadinc.

[LifeAhead @Lifeaheadinc]

Link: https://t.co/YSPAhV5585

We’re building LifeAhead to improve the status quo of information for women's reproductive health. That starts with protecting the infrastructure of science itself.

[LifeAhead @Lifeaheadinc]

Proud to share LifeAhead cofounder Josh Johnson's authorship on a new NEJM piece out today on the growing threats to women’s health research in the U.S. What’s happening behind the scenes right now has massive implications not just for women, but for future innovation.